The Business Times
business-time-50

Biolidics launches IPO to raise S$6.1m

google-preferred-sourceAdd BT as a preferred source
Published Tue, Dec 11, 2018 · 09:50 PM

    Singapore

    MEDICAL technology company Biolidics on Tuesday launched an initial public offering (IPO) of 27.5 million new shares at S$0.28 each. The placement is in conjunction with its proposed listing on the Catalist board on Dec 19.

    The shares will be placed out to retail and institutional investors in Singapore, and represent 11.34 per cent of the company's enlarged share capital. Upon completion of the IPO, Biolidics' market capitalisation is expected to be S$67.9 million.

    Biolidics

    TRENDING NOW

    UOB group chief financial officer Leong Yung Chee (left) and AllianzGI CEO Tobias Pross at the signing of the strategic distribution partnership.

    UOB to sell asset management arm to Allianz Global Investors for S$555 million, sharpen wealth advisory focus

    Grant Wee built Hideaway as a massage-and-bathhouse concept centred on solitude and recovery.

    UOB CEO’s youngest child Grant Wee turns burnout into a wellness business

    Out of the 18,000 fresh graduates, 9,100 have found employment and 5,400 are outside the labour force, mainly for voluntary reasons.

    1 in 5 fresh graduates from autonomous universities still seeking employment: MOM

    Yeoh Pei Xien is the youngest grandchild of Yeoh Tiong Lay, who founded Malaysian multinational conglomerate YTL Corporation.

    Yeoh Pei Xien: YTL’s third-gen scion with a pastor’s heart

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More